Skip to main content
. 2013 Dec 23;36(1):22–29. doi: 10.1097/MPH.0000000000000039

FIGURE 1.

FIGURE 1

Treatment framework and minimal residual disease (MRD) stratification in the ALL2004 study. Patients with MRD levels ≥10−3 at week 12 received salvage therapy (dotted arrows), whereas the remainder continued to receive the initial risk-adapted therapy (solid arrows). Treatment schedules are shown in Table 1. CRT indicates cranial radiotherapy; HR, high-risk group; HHR, high-high-risk group; SR, standard-risk group.